1. Home
  2. ZLAB vs BMA Comparison

ZLAB vs BMA Comparison

Compare ZLAB & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • BMA
  • Stock Information
  • Founded
  • ZLAB 2013
  • BMA 1966
  • Country
  • ZLAB China
  • BMA Argentina
  • Employees
  • ZLAB N/A
  • BMA N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • BMA Commercial Banks
  • Sector
  • ZLAB Health Care
  • BMA Finance
  • Exchange
  • ZLAB Nasdaq
  • BMA Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • BMA 4.2B
  • IPO Year
  • ZLAB 2017
  • BMA 2006
  • Fundamental
  • Price
  • ZLAB $33.34
  • BMA $58.15
  • Analyst Decision
  • ZLAB Buy
  • BMA Buy
  • Analyst Count
  • ZLAB 6
  • BMA 2
  • Target Price
  • ZLAB $57.22
  • BMA $50.75
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • BMA 410.4K
  • Earning Date
  • ZLAB 08-07-2025
  • BMA 08-27-2025
  • Dividend Yield
  • ZLAB N/A
  • BMA 1.28%
  • EPS Growth
  • ZLAB N/A
  • BMA N/A
  • EPS
  • ZLAB N/A
  • BMA 0.40
  • Revenue
  • ZLAB $427,799,000.00
  • BMA $2,570,483,049.00
  • Revenue This Year
  • ZLAB $42.62
  • BMA N/A
  • Revenue Next Year
  • ZLAB $55.12
  • BMA $11.90
  • P/E Ratio
  • ZLAB N/A
  • BMA $13.91
  • Revenue Growth
  • ZLAB 32.56
  • BMA N/A
  • 52 Week Low
  • ZLAB $18.91
  • BMA $54.53
  • 52 Week High
  • ZLAB $44.34
  • BMA $118.42
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • BMA 33.63
  • Support Level
  • ZLAB $31.79
  • BMA $56.36
  • Resistance Level
  • ZLAB $35.45
  • BMA $61.18
  • Average True Range (ATR)
  • ZLAB 1.00
  • BMA 3.34
  • MACD
  • ZLAB -0.22
  • BMA -1.11
  • Stochastic Oscillator
  • ZLAB 31.12
  • BMA 17.99

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

Share on Social Networks: